Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FHGU1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,097
Award facts
- Contract value 100% obligated
- $34,097.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,097.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award was issued on December 5, 2025, with an ultimate completion date of December 29, 2025, under a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
The PPV-G GEN V program represents part of the Defense Logistics Agency's broader $30.3 billion pharmaceutical acquisition strategy designed to supply the Department of Defense's military healthcare facilities worldwide with a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's selection as a regional prime vendor contractor demonstrates its established capability to support recurring medical supply needs across the federal military medical system. The company's substantial contracting activity with the Defense Logistics Agency prior to this award, involving delivery orders spanning multiple therapeutic categories and product lines, positions it as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHGU1?
SPE2DR26FHGU1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FHGU1 worth?
The government has obligated $34,097 on SPE2DR26FHGU1.
Is contract SPE2DR26FHGU1 an order under another contract?
Yes. SPE2DR26FHGU1 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGU1 competed?
The extent of competition for SPE2DR26FHGU1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award